Skip to main content

Best Gennev Alternative for Perimenopause Tracking

Last updated: April 2, 2026

TLDR

Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. It is no longer an independent platform. Horiva is independently built, stores data on-device, and costs $9/mo with no corporate healthcare parent.

Quick Verdict

Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. It is no longer an independent platform. Horiva is independently built, stores data on-device, and costs $9/mo with no corporate healthcare parent.

Gennev was acquired in October 2022 by Unified Women's Healthcare, now integrated with 2,700+ providers

Source: Market analysis, acquisition reporting

Gennev reported over 1M users accessing educational content before acquisition

Source: Gennev public reporting

COMPETITOR

Gennev
Acquired by large healthcare corporation - no longer independent, employer-plan dependent for access
Feature Gennev Horiva
Monthly cost Varies by employer plan $9/mo
Data privacy model Varies by app On-device only - we never see it
Perimenopause support Varies by app Built specifically for perimenopause
Doctor reports Varies by app Yes - PDF export
Free entry path Varies by app Pick a plan first

Horiva is $9/mo with no data selling — vs. Gennev at Varies by employer plan.

Why Women Search for Gennev Alternatives

Gennev launched as an independent menopause health platform offering coaching, telehealth, and educational content. Over 1 million users accessed its educational resources.

In October 2022, Gennev was acquired by Unified Women’s Healthcare, a company operating a network of 2,700+ OB-GYN and women’s health providers. The acquisition shifted Gennev from an independent digital health startup to a component of a large healthcare corporation.

For women who valued Gennev’s independence, that raises real questions: who owns your data now, and do the platform’s incentives still align with you rather than corporate healthcare revenue?

What Gennev Got Right

Gennev’s educational content reached a large audience and helped normalize conversations about menopause. The coaching model gave women access to menopause-informed guidance at a time when most primary care providers had minimal training on the topic.

The Unified Women’s Healthcare integration also means coordinated care across a large provider network, which could help women already within that system.

Where Gennev Falls Short Now

The acquisition changed the access model. Gennev’s services are increasingly tied to employer health plans rather than available as a direct consumer purchase. If your employer does not offer Gennev through its benefits, getting access is less straightforward than it used to be.

Your health data also now lives within a corporate healthcare system. Gennev’s original patient-first promise looks different when the parent company runs 2,700+ clinical practices with their own revenue targets.

The coaching model also creates natural upsell pressure. Free educational content leads to paid coaching sessions, which lead to clinical referrals within the Unified network.

How Horiva Compares

Horiva is independently built with no corporate healthcare parent. We are a small team that built a tracking tool because we saw that perimenopause symptom logging was either nonexistent or buried inside apps designed for regular menstrual cycles.

At $9/mo, you get a 40+ symptom library, on-device data storage, and doctor-ready reports you can take to any provider you choose. Your data stays on your phone. We cannot access it, which means we cannot share it with a parent company, an employer, or an insurance network.

Independence matters when it comes to health tracking. The tool that records your most sensitive health data should not answer to a corporate healthcare system.

Q&A

What happened to Gennev and is there an alternative?

Gennev was acquired by Unified Women's Healthcare in October 2022 and integrated into a 2,700+ provider network. If you want independent perimenopause tracking without corporate healthcare ownership, Horiva offers on-device symptom logging at $9/mo with no employer plan requirement.

Q&A

Is there a Gennev alternative for independent perimenopause tracking?

Horiva is built as an independent, privacy-first tracker for perimenopause. Unlike Gennev, which now operates under Unified Women's Healthcare, Horiva stores all data on-device with no corporate parent. At $9/mo direct-to-consumer, it does not depend on employer plans for access.

PROS & CONS

Gennev

Pros

  • Integrated with 2,700+ provider network through Unified Women's Healthcare
  • Over 1M users accessed educational content pre-acquisition
  • Clinical integration means potential for coordinated care across providers

Cons

  • No longer an independent company - acquired by Unified Women's Healthcare in October 2022
  • Access increasingly tied to employer health plans rather than direct consumer purchase
  • Coaching model creates upsell pressure toward paid consultations
  • Health data now sits within a large corporate healthcare system

Frequently asked

Common questions before you try it

What happened to Gennev?
Gennev was acquired by Unified Women's Healthcare in October 2022. It has been integrated into their network of 2,700+ providers. The platform still exists but is no longer an independent startup - it operates under corporate healthcare ownership.
Is Gennev still available as a standalone app?
Gennev's services are increasingly tied to employer health plans through Unified Women's Healthcare. Direct consumer access may be limited depending on your employer and insurance situation. The original direct-to-consumer model has shifted.
Can I get perimenopause tracking without an employer health plan?
Yes. Horiva is a direct-to-consumer tracking app at $9/mo with no employer plan or insurance requirement. You sign up, start tracking, and your data stays on your device. No corporate healthcare system involved.

Still have questions?

Start tracking free for 30 days